Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tegafur/uracil
i
Other names:
BMS 200604 01
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Generic mfg.
Drug class:
Thymidylate synthase inhibitor
Related drugs:
‹
5-fluorouracil (143)
capecitabine (81)
pemetrexed (58)
gimeracil/oteracil/tegafur (7)
raltitrexed (3)
arfolitixorin (2)
pemetrexed RTD (1)
fluorouracil topical (1)
NUC-3373 (1)
pemetrexed (0)
TG6002 (0)
nolatrexed (0)
doxifluridine (0)
LY01616 (0)
levoleucovorin calcium (0)
DB107 (0)
5-fluorouracil (143)
capecitabine (81)
pemetrexed (58)
gimeracil/oteracil/tegafur (7)
raltitrexed (3)
arfolitixorin (2)
pemetrexed RTD (1)
fluorouracil topical (1)
NUC-3373 (1)
pemetrexed (0)
TG6002 (0)
nolatrexed (0)
doxifluridine (0)
LY01616 (0)
levoleucovorin calcium (0)
DB107 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HR negative
HER2 Positive Breast Cancer
HR negative
HER2 Positive Breast Cancer
tegafur/uracil
Sensitive: C3 – Early Trials
tegafur / uracil
Sensitive
:
C3
tegafur/uracil
Sensitive: C3 – Early Trials
tegafur / uracil
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login